Matthieu BASTIDE
Matthieu BASTIDE
Verified email at u-bordeaux.fr - Homepage
TitleCited byYear
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
MF Bastide, WG Meissner, B Picconi, S Fasano, PO Fernagut, M Feyder, ...
Progress in neurobiology 132, 96-168, 2015
2432015
Selective inactivation of striatal FosB/ΔFosB-expressing neurons alleviates L-DOPA–induced dyskinesia
M Engeln, MF Bastide, E Toulmé, B Dehay, M Bourdenx, E Doudnikoff, ...
Biological psychiatry 79 (5), 354-361, 2016
642016
Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia
MF Bastide, S Dovero, G Charron, G Porras, CE Gross, PO Fernagut, ...
Neurobiology of disease 62, 179-192, 2014
592014
Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression
M Bourdenx, S Dovero, M Engeln, S Bido, MF Bastide, N Dutheil, ...
Acta neuropathologica communications 3 (1), 46, 2015
512015
Inhibiting lateral habenula improves L-DOPA–induced dyskinesia
MF Bastide, B de la Crompe, E Doudnikoff, PO Fernagut, CE Gross, ...
Biological psychiatry 79 (5), 345-353, 2016
132016
Spinal miRNA-124 regulates synaptopodin and nociception in an animal model of bone cancer pain
S Elramah, MJ López-González, M Bastide, F Dixmérias, O Roca-Lapirot, ...
Scientific reports 7 (1), 1-13, 2017
92017
Striatal NELF-mediated RNA polymerase II stalling controls l-dopa induced dyskinesia
MF Bastide, S Bido, N Duteil, E Bézard
Neurobiology of disease 85, 93-98, 2016
42016
Basal ganglia circuitry models of levodopa-induced dyskinesia
WKD Ko, M Bastide, E Bezard
Levodopa-Induced Dyskinesia in Parkinson's Disease, 109-134, 2014
22014
Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesia
MF Bastide, C Glangetas, E Doudnikoff, Q Li, M Bourdenx, PO Fernagut, ...
Scientific reports 7 (1), 1-7, 2017
12017
L-dopa induced dyskinesia in Parkinson's disease
MF Bastide, E Bézard
Bulletin de l'Academie nationale de medecine 199 (2-3), 201-212, 2015
12015
Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesia
F Georges, M Bastide, C Glangetas, E Doudnikoff, Q Li, M Bourdenx, ...
2017
Enhancement of lysosomal biogenesis reverse A53T mutant α-synuclein induced toxicity: Abstract# 1266
M Bourdenx, S Dovero, M Bastide, G Porras, N Dutheil, Q Li, A Ballabio, ...
Movement Disorders 30 (14), 2015
2015
Progressive nigrostriatal neurodegeneration associated with α-synuclein pathology induced by AAV-mediated overexpression of mutant α-synuclein in mice, rats and marmosets: 76
M Bourdenx, S Dovero, M Engeln, S Bido, C Piron, M Bastide, ...
Movement Disorders 30, 2015
2015
Les dyskinésies L-dopa induites dans la maladie de Parkinson
MF Bastide, E Bézard
Bulletin de l'Académie Nationale de Médecine 199 (2-3), 201-212, 2015
2015
Motor cortex acquires a pivotal role in levodopa-induced dyskinesia pathophysiology.
MF Bastide
Movement disorders: official journal of the Movement Disorder Society 28 (13 …, 2013
2013
PSD-95 expression controls L-Dopa dyskinesia
M Bastide, E Bézard
2013
DOCTORAT DE L’UNIVERSITÉ DE BORDEAUX
M BASTIDE
The system can't perform the operation now. Try again later.
Articles 1–17